Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.74 CAD | -3.52% | +9.60% | +149.09% |
22/04 | HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target | MT |
01/04 | Cardiol Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Elsley
FOU | Founder | - | 19/17/19 |
Director of Finance/CFO | - | 16/18/16 | |
Kelly Narine
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Andrew Hamer
CTO | Chief Tech/Sci/R&D Officer | 62 | 29/21/29 |
Bernard Lim
COO | Chief Operating Officer | - | 03/20/03 |
Trevor Burns
IRC | Investor Relations Contact | - | 01/17/01 |
John Geddes
PRN | Corporate Officer/Principal | - | 01/22/01 |
Corporate Officer/Principal | - | 01/15/01 | |
Thomas Moffatt
PRN | Corporate Officer/Principal | - | 01/19/01 |
Anne Tomalin
LAW | General Counsel | - | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Elsley
FOU | Founder | - | 19/17/19 |
Jennifer Chao
BRD | Director/Board Member | 54 | 15/22/15 |
Michael Willner
BRD | Director/Board Member | 57 | 07/21/07 |
Director of Finance/CFO | - | 16/18/16 | |
Peter Pekos
BRD | Director/Board Member | - | 15/17/15 |
Chairman | - | 20/18/20 | |
Teri Loxam
BRD | Director/Board Member | 51 | 19/22/19 |
Colin Stott
BRD | Director/Board Member | 57 | 03/19/03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 68,283,708 | 65,164,533 ( 95.43 %) | 0 | 95.43 % |
Company contact information
Cardiol Therapeutics, Inc.
2265 Upper Middle Road East Suite 602
L6H 0G5, Oakville
+289-910-0850
http://www.cardiolrx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+149.09% | 137M | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+46.73% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- CRDL Stock
- Company Cardiol Therapeutics Inc.